Khan, S. and Issa, H. (2026) Uncontrolled Hypothyroidism with Antiphospholipid Syndrome Resulting in Myxedema Psychosis. Open Journal of Psychiatry, 16, 131-138. doi: 10.4236/ojpsych.2026.162010 .
Add Yahoo as a preferred source to see more of our stories on Google. This week's episode of The Pitt tackled a very sensitive subject with a whole lot of care and grace when a victim of assault ...
AbbVie commits to lowering Medicaid drug prices and investing $100 billion in US R&D and capital investments over the next decade. The TrumpRx program will expand direct-to-patient offerings, ...
CINCINNATI (WKRC) - The FDA upgraded a recall for a commonly prescribed medication that may pose a health risk. According to an updated enforcement report from the Food and Drug Administration, 54,532 ...
Everyday Health on MSN

Levothyroxine & Caffeine

Find out how levothyroxine, a commonly prescribed thyroid medication, and caffeine interact. Learn how coffee and tea may affect absorption and when to have your first cup after taking your thyroid ...
The U.S. Food and Drug Administration (FDA) has upgraded a recall of a commonly prescribed thyroid medication due to what it described as "subpotent" active ingredients. The recall of more than ...
Patritumab Deruxtecan (HER3-DXd; MK-1022) in Non–Small Cell Lung Cancer After Platinum-Based Chemotherapy and Immunotherapy Many drugs in development continue to follow the historical drug development ...
Standard levothyroxine dosing algorithms that incorporate actual body mass could be responsible for the higher rate of thyrotoxicosis among older women vs men. Risk for iatrogenic thyrotoxicosis among ...
Ivermectin is a generic prescription drug used to treat specific infections from parasites. The drug comes as an oral tablet. It may be taken just once or routinely, depending on your condition.
Nov 27 (Reuters) - (This is an excerpt of the Health Rounds newsletter, where we present latest medical studies on Tuesdays and Thursdays. To receive it in your inbox for free sign up here, opens new ...